Dietary fiber-derived short-chain fatty acids: A potential therapeutic target to alleviate obesity-related nonalcoholic fatty liver disease

Obes Rev. 2021 Nov;22(11):e13316. doi: 10.1111/obr.13316. Epub 2021 Jul 18.

Abstract

Over the past several decades, increasing global prevalence of obesity-related nonalcoholic fatty liver disease (NAFLD) has been one of main challenges to human health. Recently, increasing evidence has validated connections among short chain fatty acids (SCFAs), a physiologically relevant concentration, the intestinal microbiota, and host metabolism. In this review, we summarized crosstalk between SCFAs and host metabolism in relation to NAFLD pathophysiology, focusing on recent advances. Firstly, how SCFAs are generated and absorbed under different nutritional conditions in the gut. Secondly, how SCFAs maintain gut barrier and alleviate hepatic inflammatory responses. Thirdly, how SCFAs maintain hepatic energy balance through controlling appetite and mediating the glucose homeostasis at the systemic level. Fourthly, G-protein-coupled receptors (GPRs) are widely involved in the above metabolic processes regulated by SCFAs. Overall, this review aimed to provide new insights into the prospects of SCFAs as a potential therapeutic target in management of liver diseases.

Keywords: NAFLD; SCFAs; dietary fiber; gut-liver axis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Dietary Fiber
  • Fatty Acids, Volatile
  • Gastrointestinal Microbiome*
  • Humans
  • Non-alcoholic Fatty Liver Disease* / drug therapy
  • Obesity / complications
  • Obesity / drug therapy

Substances

  • Dietary Fiber
  • Fatty Acids, Volatile